A clinical study of the restored kidney transplantation from living donors with small renal tumors by nephrectomy - A clinical study of the restored kidney transplantation from living donors with small renal tumors by nephrectomy

Tokushukai Medical Group0 个研究点目标入组 42 人开始时间: 2017年1月24日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•For Donor: 1. Patients who have received anti-cancer drugs (including molecular targeted drugs, cytokines, etc.) or other drugs within one month of nephrectomy. 2. Patients with a history of irradiation of the kidney to be removed. 3. Suspected renal tumours such as malignant lymphoma or sarcoma, or malignant tumours outside the kidney. 4. Comorbid infections (e.g. HIV, HBV, HCV) and serious illnesses. 5. Cases in which partial nephrectomy is deemed appropriate. 6. Cases other than those listed above, where the principal investigator performing the nephrectomy, the ethics review committee of the nephrectomy facility or the restorative renal transplantation review committee considers the case inappropriate as a subject. For Recipient: 1.The patient has an active infection, bleeding ulcer or malignancy. 2. The patient has a severe vascular or circulatory disorder (e.g. aortic aneurysm, cerebral thrombosis, myocardial infarction, thrombosis, pulmonary embolism), which may be exacerbated by transplantation. 3. Patients other than those listed above who are deemed inappropriate for inclusion by the transplant facility's principal investigator, the transplant facility's ethical review committee or the restorative renal transplant review committee.

发起方

Tokushukai Medical Group